It is our mission to create a new standard of care to improve the quality of life for our patients through innovation and development of new technologies in the realm of tissue engineering. The highest priority of the Riddle Institute is to bring tissue therapies to market making them readily available to patients in an efficient and timely manner once proven safe and effective. We are able to achieve this mission using an efficient business model collaborating with the best minds of tissue engineering in the industry.